ALB and melanoma: Intratumour heterogeneity in the uptake of blood-borne technetium-labelled human serum albumin (99mTc-HSA) was studied in human melanoma xenografts in an attempt to identify transport barriers leading to inadequate and heterogeneous uptake of macromolecular therapeutic agents in tumours.